The global central lab market size was evaluated at USD 3,980 million in 2024 and is expected to grow around USD 7,440 million by 2034, registering a CAGR of 6.45% from 2025 to 2034.
The central lab market refers to the production, distribution, and use of this lab, which is typically a large, specialized laboratory facility used independently of the clinical trial site or sponsor. It plays an important role in clinical research. It acts as a centralized facility that handles and analyzes samples collected at the time of clinical trials. There is a high demand for these labs in infectious diseases, cardiology, neurology, and oncology applications, which is driving the growth of the central lab market.
These labs are responsible for handling a significant portion of the laboratory testing needed for the clinical trial.
However, the challenging market factors include stringent government regulations & compliance, regulatory difficulties, high cost of raw materials, supply chain disruptions, and high initial investment that can limit the market's growth. The future scope of the market includes technological innovation in testing equipment, digitalization, reducing costs, investment in infrastructure development, integration of supportive government policies, integration of AI & IoT, increasing consumer awareness, and advancement in technology that will help the growth of the central lab market.